Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 26

The Research Roundup provides an overview of the past week’s research from Mayo Medical Laboratories consultants, including featured abstracts and complete list of published studies and reviews.


Featured Abstract

Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation

cardio-960x540Studies suggesting that B-type natriuretic peptide (BNP) may predict outcomes of mitral regurgitation (MR) are plagued by small size, inconsistent etiologies, and lack of accounting for shifting normal BNP ranges with age and sex. Mayo Clinic researchers conducted a study to assess the effect of BNP activation on mortality in a large, multicenter cohort of patients with degenerative MR. The study found that in patients with degenerative MR, BNP ratio is a powerful, independent, and incremental predictor of long-term mortality under medical management. BNP ratio should be incorporated into the routine clinical assessment of patients with degenerative MR. The study was published in the Journal of the American College of Cardiology


Published to PubMed This Week

brentwestra

Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.